KPRX
Kiora Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.09
-0.06 ▼ -2.79%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$2.09
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -2.46 | Insider Own | 8.72% | Shs Outstand | 0.00B | Perf Week | 5.56% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | -30.41% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -2.34% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -0.67 | Inst Own | 37.1% | Short Float | 0.24% | Perf Quarter | -1.42% |
| Income | -0.01B | P/S | - | EPS this Y | -296.55% | Inst Trans | 2.87% | Short Ratio | 0.18 | Perf Half Y | -22.59% |
| Sales | 0.00B | P/B | 0.32 | EPS next 5Y | - | ROA | -24.99% | Short Interest | 0.01M | Perf YTD | 6.09% |
| Book/sh | 6.53 | P/C | 0.4 | EPS past 3/5Y | - | ROE | -32.58% | 52W High | -50% ($4.18) | Perf Year | -35.69% |
| Cash/sh | 5.27 | P/FCF | - | Sales past 3/5Y | - 42.93% | ROIC | -37.7% | 52W Low | 18.45% ($1.76) | Perf 3Y | -93.67% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -463.97% | Gross Margin | - | Volatility(W/M) | 5.44% 4.41% | Perf 5Y | -99.9% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.1 | Perf 10Y | -99.99% |
| Dividend Ex-Date | - | Quick Ratio | 8.79 | EPS Q/Q | 100.77% | Profit Margin | - | RSI (14) | 49.18 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.79 | Sales Q/Q | - | SMA20 | 1.24% ($2.06) | Beta | -0.83 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 11000000 | SMA50 | -1.84% ($2.13) | Rel Volume | 0.44 | Prev Close | $2.15 |
| Employees | 12 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 101.36% -100% | SMA200 | -15.97% ($2.49) | Avg Volume(3M) | 0.05M | Price | $2.09 |
| IPO | 2015/2/13 | Option/Short | No/Yes | Trades | 111 | Volume | 20,500 | Change | -2.79% |
뉴스 로딩 중...